|
?:authorAffiliation
|
-
[\'Level 7, Monash Health Translational Precinct, 246 Clayton Rd, Clayton, Melbourne, VIC, 3168, Australia. amy.body@monash.edu.\', \'Monash University, Clayton, Melbourne, VIC, 3168, Australia. amy.body@monash.edu.\', \'Level 7, Monash Health Translational Precinct, 246 Clayton Rd, Clayton, Melbourne, VIC, 3168, Australia.\', \'Monash University, Clayton, Melbourne, VIC, 3168, Australia.\', \'Kids Cancer Centre, Sydney Children\'s Hospital\', Randwick, NSW, 2031, Australia.\', \'School of Women\'s & Children\'s Health, Faculty of Medicine, University of New South Wales, Sydney, 2052, Australia.\', \'Children\'s Cancer Centre, Monash Children\'s Hospital, 246 Clayton Rd, Clayton, Melbourne, VIC, 3168, Australia.\', \'Immunovirology and Pathogenesis Program, The Kirby Institute, University of New South Wales, Kensington, Sydney NSW, 2052, Australia.\', \'QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.\', \'The Kirby Institute, University of New South Wales, Kensington, Sydney NSW, 2052, Australia.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}